Currently, there have been two main kinds of cellular antigens used as feasible targets in cervical cancer for ADCs, TF (tissue factor) and Trop2 (anti-human trophoblast cell-surface marker) (80, 82). The gene discussed is TACSTD2; the disease is cervical carcinoma.